{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T05:14:11Z","timestamp":1762492451184,"version":"build-2065373602"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,3,14]],"date-time":"2020-03-14T00:00:00Z","timestamp":1584144000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"GABI-R"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IJC Heart & Vasculature"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.ijcha.2020.100501","type":"journal-article","created":{"date-parts":[[2020,3,20]],"date-time":"2020-03-20T13:03:50Z","timestamp":1584709430000},"page":"100501","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Two year efficacy and safety of small versus large ABSORB bioresorbable vascular scaffolds of \u226418\u00a0mm device length: A subgroup analysis of the German-Austrian ABSORB RegIstRy (GABI-R)"],"prefix":"10.1016","volume":"27","author":[{"given":"Myron","family":"Zaczkiewicz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bastian","family":"Wein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Graf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliver","family":"Zimmermann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes","family":"Kastner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jochen","family":"W\u00f6hrle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riemer","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Hamm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Torzewski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcha.2020.100501_b0005","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1056\/NEJMoa1509038","article-title":"Everolimus-eluting bioresorbable scaffolds for coronary artery disease","volume":"373","author":"Ellis","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcha.2020.100501_b0010","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S0140-6736(17)31470-8","article-title":"2-year outcomes with the Absorb bioresorbable scaffold for treatment of coronary artery disease: a systematic review and meta-analysis of seven randomised trials with an individual patient data substudy","volume":"390","author":"Ali","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.ijcha.2020.100501_b0015","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1016\/j.jacc.2017.10.010","article-title":"3-Year clinical outcomes with everolimus-eluting bioresorbable coronary scaffolds: The ABSORB III trial","volume":"70","author":"Kereiakes","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcha.2020.100501_b0020","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0140-6736(15)00979-4","article-title":"Everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting metallic stents: a meta-analysis of randomised controlled trials","volume":"387","author":"Cassese","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.ijcha.2020.100501_b0025","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1016\/S0140-6736(16)32050-5","article-title":"Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial","volume":"388","author":"Serruys","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.ijcha.2020.100501_b0030","doi-asserted-by":"crossref","unstructured":"J.J. Wykrzykowska, R.P. Kraak, S.H. Hofma, R.J. van der Schaaf, E.K. Arkenbout, A.J. IJsselmuiden, J. Elias, I.M. van Dongen, R.Y.G. Tijssen, K.T. Koch, J. Jr. Baan, M.M. Vis, R.J. de Winter, J.J. Piek, J.G.P Tijssen, J.P.S. Henriques. Bioresorbable Scaffolds versus Metallic Stents in Routine PCI, N. Engl. J. Med., 376 (2017) 2319\u20132328.","DOI":"10.1056\/NEJMoa1614954"},{"key":"10.1016\/j.ijcha.2020.100501_b0035","doi-asserted-by":"crossref","unstructured":"Caixeta, A., Campos, C.M., Felix, C., Chieffo, A., Capranzano, P., Kawamoto, H., Tamburino, C., Diletti, R., de Ribamar Costa, J. Jr., Onuma, Y., van Geuns, R.J., Bartorelli, A.L., Colombo, A., Tamburino, C., Serruys, P.W., Abizaid, A., 2018. Predictors of Long-term Adverse Events After Absorb Bioresorbable Vascular Scaffold Implantation: A 1,933-Patient Pooled Analysis From International Registries. EuroIntervention. https:\/\/doi.org\/10.4244\/EIJ-D-16-00796.","DOI":"10.4244\/EIJ-D-16-00796"},{"key":"10.1016\/j.ijcha.2020.100501_b0040","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.jacc.2015.12.019","article-title":"Bioresorbable coronary scaffold thrombosis: multicenter comprehensive analysis of clinical presentation mechanisms, and predictors","volume":"67","author":"Puricel","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcha.2020.100501_b0045","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1016\/j.jacc.2017.09.1106","article-title":"Effect of technique on outcomes following bioresorbable vascular scaffold implantation: analysis from the ABSORB trials","volume":"70","author":"Stone","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcha.2020.100501_b0050","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1016\/S0140-6736(18)32283-9","article-title":"Kereiakes. Blinded outcomes and angina assessment of coronary bioresorbable scaffolds: 30-day and 1-year results from the ABSORB IV randomised trial","volume":"392","author":"Stone","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.ijcha.2020.100501_b0055","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.carrev.2015.09.002","article-title":"Evaluation of the short- and long-term safety and therapy outcomes of the everolimus-eluting bioresorbable vascular scaffold system in patients with coronary artery stenosis: Rationale and design of the German-Austrian ABSORB RegIstRy (GABI-R)","volume":"17","author":"Nef","year":"2016","journal-title":"Cardiovasc. Revasc. Med."},{"key":"10.1016\/j.ijcha.2020.100501_b0060","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.4244\/EIJ-D-17-00330","article-title":"Everolimus-eluting bioresorbable scaffolds in patients with coronary artery disease: results from the German-Austrian ABSORB RegIstRy (GABI-R)","volume":"13","author":"Nef","year":"2017","journal-title":"EuroIntervention"},{"key":"10.1016\/j.ijcha.2020.100501_b0065","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/MCA.0000000000000618","article-title":"Predictors of early scaffold thrombosis: results from the multicenter prospective German-Austrian ABSORB RegIstRy","volume":"29","author":"Wohrle","year":"2018","journal-title":"Coron. Artery Dis."},{"key":"10.1016\/j.ijcha.2020.100501_b0070","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","article-title":"Clinical end points in coronary stent trials: a case for standardized definitions","volume":"115","author":"Cutlip","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.ijcha.2020.100501_b0075","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/clc.22855","article-title":"Safety and efficacy of second-generation drug-eluting stents compared with bare-metal stents: An updated meta-analysis and regression of 9 randomized clinical trials","volume":"41","author":"Mahmoud","year":"2018","journal-title":"Clin. Cardiol."},{"key":"10.1016\/j.ijcha.2020.100501_b0080","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1016\/S0140-6736(17)32249-3","article-title":"Ultrathin, Bioresorbable polymer sirolimus-eluting stents versus thin, durable polymer everolimus-eluting stents in patients undergoing coronary revascularisation (BIOFLOW V): a randomised trial","volume":"390","author":"Kandzari","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.ijcha.2020.100501_b0085","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0140-6736(18)31719-7","article-title":"Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomised non-inferiority trial","volume":"392","author":"Jeger","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.ijcha.2020.100501_b0090","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1093\/eurheartj\/ehy710","volume":"40","author":"Byrne","year":"2019","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcha.2020.100501_b0095","article-title":"Safety and performance of a resorbable magnesium scaffold under real-world conditions: 12-month outcomes of the first 400 patients enrolled in the BIOSOLVE-IV registry","author":"Verheye","year":"2019","journal-title":"EuroIntervention"}],"container-title":["IJC Heart & Vasculature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352906719303082?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352906719303082?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T05:09:15Z","timestamp":1762492155000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352906719303082"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":19,"alternative-id":["S2352906719303082"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcha.2020.100501","relation":{},"ISSN":["2352-9067"],"issn-type":[{"type":"print","value":"2352-9067"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Two year efficacy and safety of small versus large ABSORB bioresorbable vascular scaffolds of \u226418\u00a0mm device length: A subgroup analysis of the German-Austrian ABSORB RegIstRy (GABI-R)","name":"articletitle","label":"Article Title"},{"value":"IJC Heart & Vasculature","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcha.2020.100501","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100501"}}